CONGRESSES

Our medical oncologists and laboratory investigators are regular speakers and organizers of some of the most important international seminars and scientific meetings.

We have presented the results of our investigations into the causes of cancer and novel treatments at some of the most important national and international oncology congresses.

BROWSE CONGRESSES
BY YEAR

American Association for Cancer Research (AACR) Annual Meeting

DATE31/03/2012 - 05/04/2012

PLACEChicago U.S.A.

Correlation between BRCA1 and LMO4 mRNA expression levels in erlotinib- treated NSCLC patients with EGFR mutations Costa C, PhD

Mutations in p53 are associated with shorter time to progression (TTP) and overall survival (OS) in erlotinib-treated, EGFR-mutated patients Molina M.D, PhD

23nd International Congress on Anti-Cancer Treatment (ICACT)

DATE31/01/2012 - 02/02/2012

PLACEParis, France

The predictive role of signalling networks involved in advanced lung cancer Rosell R, MD, PhD. Presidential session

Cancer translational research Rosell R, MD, PhD

Lung cancer customized treatment Rosell R, MD, PhD

10th Annual British Thoracic Oncology Group Conference

DATE25/01/2012

PLACEDublin, Ireland

Growth factors and DNA repair Rosell R, MD, PhD

Spanish Lung Cancer Group 9th Congress on Lung Cancer

DATE17/11/2011 - 18/11/2011

PLACEBarcelona, Spain

Moving forward to saving lives in NSCLC: Can CSCs be detected in rebiopsies? Rosell R, MD, PhD

European Multidisciplinary Congress in Thoracic Oncology (EMCTO)

DATE24/02/2011

PLACELugano, Switzerland

Presentation and Discussion of the Lugano Consensus: Pathology and Molecular Testing Rosell R, MD, PhD